← Yangiliklar markaziga qaytish
Sog‘liq
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
Manba: U.S. Food and Drug Administration (FDA)
E’lon qilingan:
Tarjima qilinmagan — asl tilda ko‘rsatilgan (ingliz tili).
Manba bergan mazmun — U.S. Food and Drug Administration (FDA)
FDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack.
Bu sahifada nashriyot bildirgan ma’lumot keltirilgan. MYITEDU bu da’volarni mustaqil tekshirmagan.
Asl maqolani o‘qish — U.S. Food and Drug Administration (FDA) ↗
Manba ko‘rsatilishi: Source: U.S. Food and Drug Administration (fda.gov)
Ulashish
Instagram saytlardan havola ulashishni qo‘llab-quvvatlamaydi. Kartani yuklab oling, Instagram ilovasida joylang va izohni qo‘ying.
Tuzatish haqida xabar berish
Materialdagi, tarjimadagi, sanadagi yoki manba ko‘rsatilishidagi xato haqida xabar bering. Aloqa ma’lumotlaringiz maxfiy saqlanadi va faqat javob berish uchun ishlatiladi.